Portal htn Definition

Reading File
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Reading File
Here is a comprehensive, textbook-sourced answer on the definition of portal hypertension:

Portal Hypertension - Definition

Core Definition

Portal hypertension is a clinical syndrome defined as an abnormal elevation of pressure in the portal venous system. It develops when resistance to portal blood flow increases, leading to a pressure gradient above normal.
It is most precisely measured and defined using the Hepatic Venous Pressure Gradient (HVPG) - the difference between the wedged hepatic venous pressure (an approximation of portal venous pressure) and the free hepatic venous pressure (an approximation of inferior vena cava pressure), measured via hepatic vein catheterization.

HVPG Thresholds (Key Numbers)

HVPGInterpretation
3-5 mmHgNormal portal pressure
≥ 5-6 mmHgPortal hypertension (abnormal)
≥ 10 mmHgClinically Significant Portal Hypertension (CSPH) - predicts decompensation
≥ 12 mmHgThreshold for variceal formation and variceal hemorrhage risk
Different textbooks quote slightly varying cut-offs for the lower threshold (5, 6, or 7 mmHg), but agree on ≥10 mmHg for clinically significant disease.
  • Frameworks for Internal Medicine: "Portal hypertension is defined by an HVPG ≥6 mm Hg. Clinically significant portal hypertension occurs when the HVPG is ≥10 to 12 mm Hg."
  • Current Surgical Therapy 14e: "Portal hypertension is a common clinical syndrome defined by the indirect measurement of the HVPG >10 mm Hg."
  • Mulholland & Greenfield's Surgery: "Portal hypertension is defined as a portal vein pressure above the normal range of 5 to 8 mm Hg. It may also be defined by an HVPG greater than 5 mm Hg."
  • Maingot's Abdominal Operations: "Portal hypertension is present when portal venous pressure exceeds 10 mm Hg."

Classification by Anatomical Site of Obstruction

Portal hypertension is classified based on where the increased resistance occurs:
CategorySiteExamples
PrehepaticPortal or splenic veinsPortal vein thrombosis, splenic vein thrombosis
IntrahepaticWithin the liverCirrhosis (most common), schistosomiasis, NAFLD, viral hepatitis
PosthepaticHepatic veins / IVCBudd-Chiari syndrome, right heart failure, constrictive pericarditis
Note: In posthepatic portal hypertension (e.g., heart failure), both free and wedged hepatic venous pressures rise comparably, so the HVPG may NOT be elevated despite true portal hypertension.

Etiology

In North America and most of the world, cirrhosis is the leading cause (approximately 90% of cases). Cirrhosis causes:
  1. Structural/mechanical resistance - progressive collagen deposition, nodule formation, and architectural distortion of sinusoidal flow
  2. Dynamic component - hepatic stellate cell contraction and imbalance of intrahepatic vasodilators (e.g., NO) vs. vasoconstrictors
Worldwide, schistosomiasis, Budd-Chiari syndrome, and portal vein thrombosis are also frequent causes.

Pathophysiological Consequence (Simplified)

Increased portal pressure → splanchnic vasodilation → portosystemic collateral formation → complications:
  • Esophageal/gastric varices (risk of life-threatening hemorrhage)
  • Ascites (elevated hydrostatic pressure favoring fluid extravasation into peritoneum)
  • Splenomegaly with hypersplenism (anemia, thrombocytopenia)
  • Hepatic encephalopathy
  • Hepatorenal syndrome
  • Caput medusae (dilated periumbilical veins)

Gold Standard Diagnosis

The HVPG measured by hepatic vein catheterization is the gold standard. If unavailable, noninvasive markers suggesting CSPH include liver stiffness >20-25 kPa on elastography combined with low platelets, splenomegaly, or portosystemic collaterals on imaging. A SAAG ≥1.1 g/dL in ascitic fluid is highly suggestive of portal hypertension.

Sources: Frameworks for Internal Medicine, p. 166; Mulholland & Greenfield's Surgery, p. 2894; Current Surgical Therapy 14e; Maingot's Abdominal Operations, p. 1000; Sleisenger and Fordtran's GI and Liver Disease
This is a shared conversation. Sign in to Orris to start your own chat.